2-(2-(2-Methyl-3-phenylallylidene)hydrazinyl)-2-oxo-N-(m-tolyl)acetamide

Catalog No. :
ACSHPP405
CAS No. :
881664-68-2
Molecular Formula :
C19H19N3O2
Molecular Weight :
321.38

IUPAC Name:2-(2-((1E,2E)-2-methyl-3-phenylallylidene)hydrazineyl)-2-oxo-N-(m-tolyl)acetamide

2-(2-(2-Methyl-3-phenylallylidene)hydrazinyl)-2-oxo-N-(m-tolyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-(2-Methyl-3-phenylallylidene)hydrazinyl)-2-oxo-N-(m-tolyl)acetamide
IUPAC Name2-(2-((1E,2E)-2-methyl-3-phenylallylidene)hydrazineyl)-2-oxo-N-(m-tolyl)acetamide
MDL No.MFCD08282143
Molecular FormulaC19H19N3O2
Molecular Weight321.38
SMILESO=C(NC1=CC=CC(C)=C1)C(N/N=C/C(C)=C/C2=CC=CC=C2)=O
InChI KeyLABSNYRNCIPUOR-JPGHCFAASA-N
Synonym1-{N'-[(1Z,2E)-2-methyl-3-phenylprop-2-en-1-ylidene]hydrazinecarbonyl}-N-(3-methylphenyl)formamide;N-(3-METHYLPHENYL)-2-(2-(2-ME-3-PH-2-PROPENYLIDENE)HYDRAZINO)-2-OXOACETAMIDE
CAS No.881664-68-2

Safety Data

Pictogram
Harmful or irritantHealth hazardEnvironmental hazard
Signal Word
Gefahr
Hazard Statement(s)
H302-H319-H372-H410
Precautionary Statement(s)
P260-P264-P273-P301+P312-P305+P351+P338-P314

Synthetic Route by SureRoute

1. ACSHPP405 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDYGL478 route compound structure diagram
    ACDYGL47815174-47-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSHPP405 route product structure diagram
    ACSHPP405881664-68-2
Inquiry

2. ACSHPP405 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSHPP405 route product structure diagram
    ACSHPP405881664-68-2
Inquiry

Comments (0)